The cardiovascular effects induced by the aqueous fraction of the ethanol extract of the stem (AFS) of Solanum stipulaceum Roem. & Schult were studied in rats. In non-anesthetized rats, AFS injections produced significant and dosedependent hypotension associated with increase in heart rate. In isolated rat superior mesenteric rings, AFS was able to antagonize the contractions induced by phenylephrine and KCl. The vasorelaxant activity of AFS was not inhibited by either removal of vascular endothelium, L-NAME, atropine or indomethacine. In isolated rat atrial preparations, AFS produced concentration-related negative inotropic and chronotropic responses. These results suggest that the hypotensive effect of AFS is due to a peripheral vasodilation, which can not be attributed to the participation of vascular endothelium. Finally, AFS acts directly on the heart decreasing contractility and heart rate.
Material and Methods
Male Wistar rats (300-350 g) were used for all experiments. Animals were housed under conditions of controlled temperature (21±1ºC) and lighting (lights on: 06:00-18:00 h). The plant was collected in july 1999 (voucher specimen deposited in the Herbarium Prof. Lauro Pires Xavier, code Agra 5515) from the municipality of Serra Branca, state of Paraíba. The stems were separated, dried at 40 ºC in an oven and pulverized. The powder was extracted with 70% ethanol/water at room temperature for 72 h. The resulting extract was dried at 60 ºC using a rotavaporator. When required, the extract was dissolved in water and filtered.
For measurement of arterial blood pressure and heart rate, we used the technique described by Oliveira et al., 1996 6 . Superior mesenteric artery rings were isolated according to the technique described by Tanaka et al., 1999 7 . The presence of the endothelium was assessed by the ability of acetylcholine to induce more than 50% relaxation of vessels pre-contracted with phenylephrine. Rat atria were isolated according to Nasa et al., 1992 8 . Cumulative concentration-response curves were obtained by stepwise addition of AFS. IC50 values were calculated by linear regression of individual concentration-response curves. Values are expressed as mean ± s.e.mean. Statistical analysis were performed by means of paired Student's t-test when appropriate. Linear regressions were done by the least square method.
In 14 conscious rats, baseline values of mean arterial pressure and heart rate were 111±1 mmHg and 366±7 bpm, respectively. AFS produced significant and dose-dependent hypotension associated with increase in the heart rate ( Figure 1) . To test the hypothesis that AFS acts directly on resistance vessels, we used the model of small mesenteric arteries 7 . In this preparation, AFS (1, 10, 50, 100, 300, 500 mg/ml) antagonized, in a significant and concentration-dependent manner, phenylephrine (10 mM) and KCl (80 mM) induced contractions with similar potency (IC50=138±10 and 160±20 mg/ml, respectively). It is well known that the maintenance of smooth muscle contraction depends upon Ca 2+ entry from extracellular space through voltage (VOCC'S) and/or receptor operated (ROCC'S) calcium channels 9,10 . It is well known that KCl induces smooth muscle contraction through activation of VOCCs and subsequent release of calcium from the sarcoplasmic reticulum 8,11 without changing other signal transduction systems including phosphatidylinositol turnover and calcium sensitization 10 . Considering that the contractions induced by KCl were inhibited in a concentration-dependent manner by AFS, it is reasonable to suggest that this extract block VOCC's. On the other hand, it is well established that NO is a major endothelium-derived relaxing factor, both in vivo and in vitro 12 . The release of NO from endothelial cells leads to relaxation of vascular smooth muscle cells, which plays a critical role in the maintenance of vascular tone 12,13 . To determine whether part of the relaxant effect produced by AFS in isolated superior mesenteric artery could be due to NO release, we performed experiments in superior mesenteric artery preparations in which the endothelium was mechanically removed or in preparations where the rings were preincubated with L-NAME (100 mM), a competitive inhibitor of NO-synthase 13 . Under these conditions, AFS-induced smooth muscle relaxation was not attenuated (Figure 2) , indicating that relaxing factors released by the endothelium, mostly NO, do not play an important role in the vasorelaxant response induced by AFS. Furthermore, the vasorelaxant effect of AFS was unaffected by indomethacine or atropine (Figure 2) , which allowed us to definitely rule out the participation of relaxant factors released by the vascular endothelium. Finally, to investigate an additional direct cardiac action of AFS we designed experiments on isolated atrial preparations. In these preparations, AFS induced negative inotropic and chronotropic effects (IC50=516±48 and 493±55 mg/ml, respectively). In conclusion, the present study, using combined in vivo and in vitro studies, demonstrates that AFS lowers arterial pressure in rats through a decrease in peripheral vascular resistance, without the participation of endothelial cells. AFS exhibits direct cardiac-depressant properties.
